2-cyclopropyl-3-(4-fluoro-1H-indazol-5-yl)-6-[4-fluoro-3-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazine;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;3,5-difluoro-4-[6-[3-(pentafluoro-λ6-sulfanyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenol;3-fluoro-4-[5-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methyl-3aH-pyrazolo[1,5-c]pyrimidin-8-ium-3-yl]-5-methylphenol

C109H77F29N17O8P2S+ — CID 159851636

IUPAC2-cyclopropyl-3-(4-fluoro-1H-indazol-5-yl)-6-[4-fluoro-3-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazine;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;3,5-difluoro-4-[6-[3-(pentafluoro-λ6-sulfanyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenol;3-fluoro-4-[5-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methyl-3aH-pyrazolo[1,5-c]pyrimidin-8-ium-3-yl]-5-methylphenol
SMILESCC(C)c1nc2cnc(-c3ccc(F)c(C(F)(F)F)c3)cn2c1-c1c(F)cc(OP(C)(=O)O)cc1F.CC(C)c1nc2cnc(-c3cccc(S(F)(F)(F)(F)F)c3)cn2c1-c1c(F)cc(O)cc1F.CC1=C(c2c(C)cc(O)cc2F)C2C=C(c3ccc(F)c(C(F)(F)F)c3)N=C[N+]2=N1.Cc1nc2cnc(-c3ccc(F)c(C(F)(F)F)c3)cn2c1-c1c(F)cc(OP(C)(=O)O)cc1F.Fc1ccc(-c2cn3c(-c4ccc5[nH]ncc5c4F)c(C4CC4)nc3cn2)cc1C(F)(F)F
InChIInChI=1S/C23H18F6N3O3P.C23H14F5N5.C21H16F7N3OS.C21H14F6N3O3P.C21H14F5N3O/c1-11(2)21-22(20-16(25)7-13(8-17(20)26)35-36(3,33)34)32-10-18(30-9-19(32)31-21)12-4-5-15(24)14(6-12)23(27,28)29;24-16-5-3-12(7-15(16)23(26,27)28)18-10-33-19(9-29-18)31-21(11-1-2-11)22(33)13-4-6-17-14(20(13)25)8-30-32-17;1-11(2)20-21(19-15(22)7-13(32)8-16(19)23)31-10-17(29-9-18(31)30-20)12-4-3-5-14(6-12)33(24,25,26,27)28;1-10-20(19-15(23)6-12(7-16(19)24)33-34(2,31)32)30-9-17(28-8-18(30)29-10)11-3-4-14(22)13(5-11)21(25,26)27;1-10-5-13(30)7-16(23)19(10)20-11(2)28-29-9-27-17(8-18(20)29)12-3-4-15(22)14(6-12)21(24,25)26/h4-11H,1-3H3,(H,33,34);3-11H,1-2H2,(H,30,32);3-11,32H,1-2H3;3-9H,1-2H3,(H,31,32);3-9,18H,1-2H3/p+1
InChIKeyLVEWUWYMOVOJSD-UHFFFAOYSA-O
MW2397.88 g/mol
LogP32.42
Rot. Bonds18

About 2-cyclopropyl-3-(4-fluoro-1H-indazol-5-yl)-6-[4-fluoro-3-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazine;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;3,5-difluoro-4-[6-[3-(pentafluoro-λ6-sulfanyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenol;3-fluoro-4-[5-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methyl-3aH-pyrazolo[1,5-c]pyrimidin-8-ium-3-yl]-5-methylphenol

2-cyclopropyl-3-(4-fluoro-1H-indazol-5-yl)-6-[4-fluoro-3-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazine;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;3,5-difluoro-4-[6-[3-(pentafluoro-λ6-sulfanyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenol;3-fluoro-4-[5-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methyl-3aH-pyrazolo[1,5-c]pyrimidin-8-ium-3-yl]-5-methylphenol (PubChem CID 159851636) has the molecular formula C109H77F29N17O8P2S+ and a molecular weight of 2397.88 g/mol. Its IUPAC name is 2-cyclopropyl-3-(4-fluoro-1H-indazol-5-yl)-6-[4-fluoro-3-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazine;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;3,5-difluoro-4-[6-[3-(pentafluoro-λ6-sulfanyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenol;3-fluoro-4-[5-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methyl-3aH-pyrazolo[1,5-c]pyrimidin-8-ium-3-yl]-5-methylphenol.

Molecular Properties

Compound Name2-cyclopropyl-3-(4-fluoro-1H-indazol-5-yl)-6-[4-fluoro-3-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazine;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;3,5-difluoro-4-[6-[3-(pentafluoro-λ6-sulfanyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenol;3-fluoro-4-[5-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methyl-3aH-pyrazolo[1,5-c]pyrimidin-8-ium-3-yl]-5-methylphenol
PubChem CID159851636
Molecular FormulaC109H77F29N17O8P2S+
Molecular Weight2397.88 g/mol
Exact Mass2396.49
IUPAC Name2-cyclopropyl-3-(4-fluoro-1H-indazol-5-yl)-6-[4-fluoro-3-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazine;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;3,5-difluoro-4-[6-[3-(pentafluoro-λ6-sulfanyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenol;3-fluoro-4-[5-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methyl-3aH-pyrazolo[1,5-c]pyrimidin-8-ium-3-yl]-5-methylphenol
SMILESCC(C)c1nc2cnc(-c3ccc(F)c(C(F)(F)F)c3)cn2c1-c1c(F)cc(OP(C)(=O)O)cc1F.CC(C)c1nc2cnc(-c3cccc(S(F)(F)(F)(F)F)c3)cn2c1-c1c(F)cc(O)cc1F.CC1=C(c2c(C)cc(O)cc2F)C2C=C(c3ccc(F)c(C(F)(F)F)c3)N=C[N+]2=N1.Cc1nc2cnc(-c3ccc(F)c(C(F)(F)F)c3)cn2c1-c1c(F)cc(OP(C)(=O)O)cc1F.Fc1ccc(-c2cn3c(-c4ccc5[nH]ncc5c4F)c(C4CC4)nc3cn2)cc1C(F)(F)F
InChIInChI=1S/C23H18F6N3O3P.C23H14F5N5.C21H16F7N3OS.C21H14F6N3O3P.C21H14F5N3O/c1-11(2)21-22(20-16(25)7-13(8-17(20)26)35-36(3,33)34)32-10-18(30-9-19(32)31-21)12-4-5-15(24)14(6-12)23(27,28)29;24-16-5-3-12(7-15(16)23(26,27)28)18-10-33-19(9-29-18)31-21(11-1-2-11)22(33)13-4-6-17-14(20(13)25)8-30-32-17;1-11(2)20-21(19-15(22)7-13(32)8-16(19)23)31-10-17(29-9-18(31)30-20)12-4-3-5-14(6-12)33(24,25,26,27)28;1-10-20(19-15(23)6-12(7-16(19)24)33-34(2,31)32)30-9-17(28-8-18(30)29-10)11-3-4-14(22)13(5-11)21(25,26)27;1-10-5-13(30)7-16(23)19(10)20-11(2)28-29-9-27-17(8-18(20)29)12-3-4-15(22)14(6-12)21(24,25)26/h4-11H,1-3H3,(H,33,34);3-11H,1-2H2,(H,30,32);3-11,32H,1-2H3;3-9H,1-2H3,(H,31,32);3-9,18H,1-2H3/p+1
InChIKeyLVEWUWYMOVOJSD-UHFFFAOYSA-O
XLogP32.42
TPSA310.69 Ų
H-Bond Donors5
H-Bond Acceptors21
Rotatable Bonds18
Heavy Atoms166
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002397.88
LogP ≤ 532.42
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phosphor', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}

Analyze 2-cyclopropyl-3-(4-fluoro-1H-indazol-5-yl)-6-[4-fluoro-3-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazine;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;3,5-difluoro-4-[6-[3-(pentafluoro-λ6-sulfanyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenol;3-fluoro-4-[5-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methyl-3aH-pyrazolo[1,5-c]pyrimidin-8-ium-3-yl]-5-methylphenol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-cyclopropyl-3-(4-fluoro-1H-indazol-5-yl)-6-[4-fluoro-3-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazine;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;3,5-difluoro-4-[6-[3-(pentafluoro-λ6-sulfanyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenol;3-fluoro-4-[5-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methyl-3aH-pyrazolo[1,5-c]pyrimidin-8-ium-3-yl]-5-methylphenol?
The IUPAC name of 2-cyclopropyl-3-(4-fluoro-1H-indazol-5-yl)-6-[4-fluoro-3-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazine;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;3,5-difluoro-4-[6-[3-(pentafluoro-λ6-sulfanyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenol;3-fluoro-4-[5-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methyl-3aH-pyrazolo[1,5-c]pyrimidin-8-ium-3-yl]-5-methylphenol (CID 159851636) is 2-cyclopropyl-3-(4-fluoro-1H-indazol-5-yl)-6-[4-fluoro-3-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazine;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;3,5-difluoro-4-[6-[3-(pentafluoro-λ6-sulfanyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenol;3-fluoro-4-[5-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methyl-3aH-pyrazolo[1,5-c]pyrimidin-8-ium-3-yl]-5-methylphenol.
What is the SMILES notation for 2-cyclopropyl-3-(4-fluoro-1H-indazol-5-yl)-6-[4-fluoro-3-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazine;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;3,5-difluoro-4-[6-[3-(pentafluoro-λ6-sulfanyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenol;3-fluoro-4-[5-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methyl-3aH-pyrazolo[1,5-c]pyrimidin-8-ium-3-yl]-5-methylphenol?
The canonical SMILES for 2-cyclopropyl-3-(4-fluoro-1H-indazol-5-yl)-6-[4-fluoro-3-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazine;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;3,5-difluoro-4-[6-[3-(pentafluoro-λ6-sulfanyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenol;3-fluoro-4-[5-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methyl-3aH-pyrazolo[1,5-c]pyrimidin-8-ium-3-yl]-5-methylphenol is CC(C)c1nc2cnc(-c3ccc(F)c(C(F)(F)F)c3)cn2c1-c1c(F)cc(OP(C)(=O)O)cc1F.CC(C)c1nc2cnc(-c3cccc(S(F)(F)(F)(F)F)c3)cn2c1-c1c(F)cc(O)cc1F.CC1=C(c2c(C)cc(O)cc2F)C2C=C(c3ccc(F)c(C(F)(F)F)c3)N=C[N+]2=N1.Cc1nc2cnc(-c3ccc(F)c(C(F)(F)F)c3)cn2c1-c1c(F)cc(OP(C)(=O)O)cc1F.Fc1ccc(-c2cn3c(-c4ccc5[nH]ncc5c4F)c(C4CC4)nc3cn2)cc1C(F)(F)F.
What is the InChIKey of 2-cyclopropyl-3-(4-fluoro-1H-indazol-5-yl)-6-[4-fluoro-3-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazine;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;3,5-difluoro-4-[6-[3-(pentafluoro-λ6-sulfanyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenol;3-fluoro-4-[5-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methyl-3aH-pyrazolo[1,5-c]pyrimidin-8-ium-3-yl]-5-methylphenol?
The InChIKey is LVEWUWYMOVOJSD-UHFFFAOYSA-O. The full InChI is InChI=1S/C23H18F6N3O3P.C23H14F5N5.C21H16F7N3OS.C21H14F6N3O3P.C21H14F5N3O/c1-11(2)21-22(20-16(25)7-13(8-17(20)26)35-36(3,33)34)32-10-18(30-9-19(32)31-21)12-4-5-15(24)14(6-12)23(27,28)29;24-16-5-3-12(7-15(16)23(26,27)28)18-10-33-19(9-29-18)31-21(11-1-2-11)22(33)13-4-6-17-14(20(13)25)8-30-32-17;1-11(2)20-21(19-15(22)7-13(32)8-16(19)23)31-10-17(29-9-18(31)30-20)12-4-3-5-14(6-12)33(24,25,26,27)28;1-10-20(19-15(23)6-12(7-16(19)24)33-34(2,31)32)30-9-17(28-8-18(30)29-10)11-3-4-14(22)13(5-11)21(25,26)27;1-10-5-13(30)7-16(23)19(10)20-11(2)28-29-9-27-17(8-18(20)29)12-3-4-15(22)14(6-12)21(24,25)26/h4-11H,1-3H3,(H,33,34);3-11H,1-2H2,(H,30,32);3-11,32H,1-2H3;3-9H,1-2H3,(H,31,32);3-9,18H,1-2H3/p+1.
What are the key properties of 2-cyclopropyl-3-(4-fluoro-1H-indazol-5-yl)-6-[4-fluoro-3-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazine;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;3,5-difluoro-4-[6-[3-(pentafluoro-λ6-sulfanyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenol;3-fluoro-4-[5-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methyl-3aH-pyrazolo[1,5-c]pyrimidin-8-ium-3-yl]-5-methylphenol?
2-cyclopropyl-3-(4-fluoro-1H-indazol-5-yl)-6-[4-fluoro-3-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazine;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;3,5-difluoro-4-[6-[3-(pentafluoro-λ6-sulfanyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenol;3-fluoro-4-[5-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methyl-3aH-pyrazolo[1,5-c]pyrimidin-8-ium-3-yl]-5-methylphenol has a molecular weight of 2397.88 g/mol, XLogP of 32.42, 18 rotatable bonds, 5 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 2-cyclopropyl-3-(4-fluoro-1H-indazol-5-yl)-6-[4-fluoro-3-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazine;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;[3,5-difluoro-4-[6-[4-fluoro-3-(trifluoromethyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenoxy]-methylphosphinic acid;3,5-difluoro-4-[6-[3-(pentafluoro-λ6-sulfanyl)phenyl]-2-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]phenol;3-fluoro-4-[5-[4-fluoro-3-(trifluoromethyl)phenyl]-2-methyl-3aH-pyrazolo[1,5-c]pyrimidin-8-ium-3-yl]-5-methylphenol is sourced from PubChem (CID 159851636), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).